DAWES KAREN A 4
4 · Barinthus Biotherapeutics plc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
DAWES KAREN A
Director
Transactions
- Award
Share Option (Right to Buy)
2025-06-10+20,174→ 20,174 totalExercise: $1.00Exp: 2035-06-10→ Ordinary Shares (20,174 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.